Its as part of Diwali 2021 stock pickingYes Securities, a domestic brokerage and research firm, has recommended twelve stocks that can be bought with a time frame of 12 months. Its top picks include Prince Pipes, Greenpal Industries, Apollo Pipes, Acrisil, Dalmia Bharat, Indiamart, PNC Infra, Polycab, ICICI Bank, Gland Pharma, SBI Cards and Crisil.
Top stocks of Yes Securities for Diwali –
Prince Pipes: The brokerage believes that the company’s strong brand image and strategic alliances are likely to expand the company’s market-share. Moreover, the industry is witnessing a meaningful transition from the unorganized to the organized segment which will enable the company to outperform the growth of the industry. its target value is ₹1,091.
Greenpanel Industries: buy tag with ‘yes’ ₹470 target price comes on the back of the company strengthening its balance sheet by reducing its total debt.
Apollo Pipes: The brokerage believes that Apollo Pipes is on the verge of becoming a major pan-India player, hence it should get the same valuation as compared to other pan-India player. yes target price ₹2,250 each on stock.
Acrysil: According to the brokerage, Acrisil Ltd is likely to become one of the biggest beneficiaries of the strong global demand for quartz sinks, with a target price of Rs. ₹995 on stock.
Dalmia India: “Strong balance sheet to support future capex: Backed by strong profitability, we expect Dalmia to generate a strong free cash flow.” Yes Securities has a target price of ₹2,640 per share.
Indiamart: The strong revenue growth outlook coupled with an increasing margin trajectory led by positive operating leverage makes it an attractive play in the online classifieds space. Brokerage sees stock as potential to rise ₹10,200 each over a period of twelve months.
PNC Infra: “Recent order flows, continued focus on asset monetization and comfortable balance sheet provide comfort.” (Target Price 460).
Polycabs: The stock is trading at a discount to the competitors of Electricals. The brokerage buy comes with a target price of the rating ₹3,300.
ICICI Bank: “At ICICI, we see potential, potentially, to increase the share of high-yield loans in a risk calibrated manner.” (Target Price 1,112).
Gland Pharma: Access to complex injections of peptides, hormones and new dosage forms such as pen, cartridge to support further growth over the next 2-3 years. Long-term ambition in biosimilars is a pivot in the right direction, said Yes Securities, suggesting a target price of ₹4,925.
SBI Card: Brokerage sees stock as potential to rise ₹10,200 in the form of new card issuance, expenses and receivables and profits should start recovering from Q2 FY22 after being hit in the preceding quarters due to the waves of the pandemic.
Crisil: “The expected revival in the domestic rating business will support the already better growth and margin trajectory of CRISIL,” Yes Securities said in the note. ₹4,460 price target for the stock.
The views and recommendations given above are those of individual analysts or broking companies and not of Mint.
Don’t miss a story! Stay connected and informed with Mint.
download
Our App Now!!
.